国产星空无限传媒|一级做a爰片|166.su吃瓜网入口|快撸视频|天天cao|爱豆传媒纹身|麻豆传媒污污片在线观看|网红打扑克网站|精品台湾swag在线播放|爱豆传媒有哪些艺人名字,麻豆映画91天美蜜桃传媒,成人国产一区二区在线,国产极品尤物逼


歐盟批準(zhǔn)轉(zhuǎn)基因大豆DAS-81419-2 及其產(chǎn)品投放市場(chǎng)

來(lái)源:食品伙伴網(wǎng) 時(shí)間: 2021-08-25


據(jù)歐盟官方公報(bào)消息,,2021817日,,歐盟委員會(huì)發(fā)布(EU2021/1386號(hào)條例,批準(zhǔn)由轉(zhuǎn)基因大豆DAS-81419-2 組成或由其生產(chǎn)的食品和飼料投放市場(chǎng),。

據(jù)了解,,該申請(qǐng)還涵蓋了批準(zhǔn)含有基因改造大豆DAS-81419-2 或由其組成的產(chǎn)品投放市場(chǎng),,這些產(chǎn)品用于除食品和飼料之外的用途(種植除外)。歐盟還在標(biāo)簽、檢測(cè)方法以及監(jiān)測(cè)環(huán)境影響等方面做了規(guī)定,。

部分原文報(bào)道如下:

 

On 9?February 2012, Dow AgroSciences Ltd, based in United Kingdom, submitted, on behalf of Dow AgroSciences LLC, based in the United States of America, an application to the national competent authority of the Netherlands for the placing on the market of foods, food ingredients and feed containing, consisting of or produced from genetically modified soybean DAS-81419-2, in accordance with Article?5 and Article?17 of Regulation (EC) No?1829/2003 (‘the application’). The application also concerned the placing on the market of products containing or consisting of genetically modified soybean DAS-81419-2 for uses other than food and feed, with the exception of cultivation.For the products covered by this Decision, no specific labelling requirements, other than those provided for in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003 and in Article 4(6) of Regulation (EC) No 1830/2003 of the European Parliament and of the Council (6), appear to be necessary. However, in order to ensure that the use of those products remains within the limits of the authorisation granted by this Decision, the labelling of the products containing or consisting of genetically modified soybean DAS-81419-2, with the exception of foods and food ingredients, should contain a clear indication that they are not intended for cultivation.The Standing Committee on Plants, Animals, Food and Feed has not delivered an opinion within the time limit laid down by its Chairman. This implementing act was deemed to be necessary and the chair submitted it to the appeal committee for further deliberation. The appeal committee did not deliver an opinion,

 

更多詳情參見(jiàn):https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv%3AOJ.L_.2021.300.01.0010.01.ENG&toc=OJ%3AL%3A2021%3A300%3ATOC?